Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-10-062275
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-16 17:33:50
Reporting Period:
2010-12-14
Filing Date:
2010-12-16
Accepted Time:
2010-12-16 17:33:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276085 S Gail Page C/o Vermillion,inc. 12117 Bee Caves Road
Building Two, Suite 100
Austin TX 78738
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-14 45,000 $5.92 139,907 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The proceeds of the sale of the 45,000 shares of common stock described in this form are intended to cover the tax liability incurred by Gail Page on the 128,580 shares distributed to her on December 10, 2010.